Replimune: The Rise Of Oncolytic Virus Therapies In Cancer Treatment Seeking Alpha, 09 Jul 2023 Summary The company's RPx platform, featuring RP1, RP2, and RP3, showcases a comprehensive and innovative approach to cancer…